Circadian Periods of Sensitivity for Ramelteon on the onset of Running-wheel Activity and the Peak of Suprachiasmatic Nucleus Neuronal Firing Rhythms in C3H/HeN Mice

REFERENCES

• Armstrong SM. (1989). Melatonin and circadian control in mammals. Experientia 45:932–938.
   PubMedGoogle Scholar
• Armstrong SM, McNulty OM, Guardiola-Lemaitre B, Redman JR. (1993). Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS). Pharmacol. Biochem. Behav. 46:45–49.
   PubMed Web of Science ®Google Scholar
• Benloucif S, Dubocovich ML. (1996). Melatonin and light induce phase shifts of circadian activity rhythms in the C3H/HeN mouse. J. Biol. Rhythms 11:113–125.
   PubMed Web of Science ®Google Scholar
• Burgess HJ, Revell VL, Eastman CI. (2008). A three pulse phase response curve to three milligrams of melatonin in humans. J. Physiol. 586:639–647.
   PubMed Web of Science ®Google Scholar
• Burgess HJ, Revell VL, Molina TA, Eastman CI. (2010). Human phase response curves to three days of daily melatonin: 0.5mg vs. 3.0mg. J. Clin. Endocrinol. Metab. 95:3325–3331.
   PubMed Web of Science ®Google Scholar
• Buysse D, Bate G, Kirkpatrick P. (2005). Fresh from the pipeline: ramelteon. Nat. Rev. Drug Discov. 4:881–882.
   PubMed Web of Science ®Google Scholar
• Cajochen C, Knoblauch V, Wirz-Justice A, Krauchi K, Graw P, Wallach D. (2004). Circadian modulation of sequence learning under high and low sleep pressure conditions. Behav. Brain Res. 151:167–176.
   PubMed Web of Science ®Google Scholar
• De Coursey PJ. (1961). Effect of light on the circadian activity rhythm of the flying squirrel. Glaucomys volans. Z. Vergl. Physiol. 44:331–354.
   Google Scholar
• Dubocovich ML. (2007). Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med. 8( Suppl 3):34–42.
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Benloucif S, Masana MI. (1996). Melatonin receptors in the mammalian suprachiasmatic nucleus. Behav. Brain Res. 73:141–147.
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Yun K, Al-Ghoul WM, Benloucif S, Masana MI. (1998). Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB. J. 12:1211–1220.
   PubMed Web of Science ®Google Scholar
• Dubocovich ML, Hudson RL, Sumaya IC, Masana MI, Manna E. (2005). Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse. J. Pineal Res. 39:113–120.
   PubMed Web of Science ®Google Scholar
• Ebihara S, Marks T, Hudson DJ, Menaker M. (1986). Genetic control of melatonin synthesis in the pineal gland of the mouse. Science 231:491–493.
   PubMed Web of Science ®Google Scholar
• Goto M, Oshima I, Tomita T, Ebihara S. (1989). Melatonin content of the pineal gland in different mouse strains. J. Pineal Res. 7:195–204.
   PubMed Web of Science ®Google Scholar
• Hartter S, Grozinger M, Weigmann H, Roschke J, Hiemke C. (2000). Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin. Pharmacol. Ther. 67:1–6.
   PubMed Web of Science ®Google Scholar
• Hirai K, Kita M, Ohta H, Nishikawa H, Fujiwara Y, Ohkawa S, Miyamoto M. (2005). Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats. J. Biol. Rhythms 20:27–37.
   PubMed Web of Science ®Google Scholar
• Hunt AE, Al-Ghoul WM, Gillette MU, Dubocovich ML. (2001). Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock [In Process Citation]. Am. J. Physiol. Cell Physiol. 280:C110–C118.
   PubMed Web of Science ®Google Scholar
• Karim A, Tolbert D, Cao C. (2006). Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. J. Clin. Pharmacol. 46:140–148.
   PubMed Web of Science ®Google Scholar
• Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M. (2005). Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology 48:301–310.
   PubMed Web of Science ®Google Scholar
• Lewy AJ, Ahmed S, Jackson JM, Sack RL. (1992). Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol. Int. 9:380–392.
   PubMed Web of Science ®Google Scholar
• Lewy AJ, Bauer VK, Ahmed S, Thomas KH, Cutler NL, Singer CM, Moffit MT, Sack RL. (1998). The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol. Int. 15:71–83.
   PubMed Web of Science ®Google Scholar
• Liu C, Weaver DR, Jin X, Shearman LP, Pieschl RL, Gribkoff VK, Reppert SM. (1997). Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19:91–102.
   PubMed Web of Science ®Google Scholar
• McArthur AJ, Hunt AE, Gillette MU. (1997). Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology 138:627–634.
   PubMed Web of Science ®Google Scholar
• Miller JD. (1993). On the nature of the circadian clock in mammals. Am. J. Physiol. 264:R821–R832.
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Nishikawa H, Doken Y, Hirai K, Uchikawa O, Ohkawa S. (2004). The sleep-promoting action of ramelteon (TAK-375) in freely moving cats. Sleep 27:1319–1325.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biologic rhythm research on laboratory animals and human beings. Chronobiol. Int. 27: 1911–1929.
   Web of Science ®Google Scholar
• Richardson GS, Zee PC, Wang-Weigand S, Rodriguez L, Peng X. (2008). Circadian phase-shifting effects of repeated ramelteon administration in healthy adults. J. Clin. Sleep Med. 4:456–461.
   PubMed Web of Science ®Google Scholar
• Roth T, Stubbs C, Walsh JK. (2005). Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Sleep 28:303–307.
   PubMed Web of Science ®Google Scholar
• Siuciak JA, Fang JM, Dubocovich ML. (1990). Autoradiographic localization of 2-[125I]iodomelatonin binding sites in the brains of C3H/HeN and C57BL/6J strains of mice. Eur. J. Pharmacol. 180:387–390.
   PubMed Web of Science ®Google Scholar
• Smith RD, Turek FW, Takahashi JS. (1992). Two families of phase-response curves characterize the resetting of the hamster circadian clock. Am. J. Physiol. 262:R1149–R1153.
   Google Scholar
• Turek FW. (1987). Pharmacological probes of the mammalian circadian clock: use of the phase response curve approach. J. Biol. Rhythms 8:212–217.
   Google Scholar
• Van Reeth O, Olivares E, Zhang Y, Zee PC, Mocaer E, Defrance R, Turek FW. (1997). Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters. Brain Res. 762:185–194.
   PubMed Web of Science ®Google Scholar
• von Gall C, Weaver DR, Kock M, Korf HW, Stehle JH. (2000). Melatonin limits transcriptional impact of phosphoCREB in the mouse SCN via the Mel1a receptor. NeuroReport 11:1803–1807.
   PubMed Web of Science ®Google Scholar
• Warren WS, Hodges DB, Cassone VM. (1993). Pinealectomized rats entrain and phase-shift to melatonin injections in a dose-dependent manner. J. Biol. Rhythms 8:233–245.
   PubMed Web of Science ®Google Scholar
• Wirz-Justice A, Werth E, Renz C, Muller S, Krauchi K. (2002). No evidence for a phase delay in human circadian rhythms after a single morning melatonin administration. J. Pineal Res. 32:1–5.
   PubMed Web of Science ®Google Scholar
• Wurtman R. (2006). Ramelteon: a novel treatment for the treatment of insomnia. Expert Rev. Neurother. 6:957–964.
   PubMedGoogle Scholar
• Yukuhiro N, Kimura H, Nishikawa H, Ohkawa S, Yoshikubo S, Miyamoto M. (2004). Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys. Brain Res. 1027:59–66.
   PubMed Web of Science ®Google Scholar
• Zaidan R, Geoffriau M, Brun J, Taillard J, Bureau C, Chazot G, Claustrat B. (1994). Melatonin is able to influence its secretion in humans: description of a phase-response curve. Neuroendocrinology 60:105–112.
   PubMed Web of Science ®Google Scholar